DSIP (Delta Sleep-Inducing Peptide) is a neuromodulator peptide investigated primarily for its effects on sleep and stress. It is still experimental, without approval for regular medical use .

Possible Benefits (Based on Limited Studies):
* Improvement in deep sleep quality (delta phase) .
* Reduction of cortisol (stress) .
* Aid in cases of insomnia .
* Potential analgesic and neuroprotective effect .
* May help in hormonal regulation, including GH .

Common Protocol (Experimental):
* Dose: 100 mcg to 500 mcg .
* Route: Subcutaneous (before bed) .
* Frequency: Daily or on alternate days .
* Duration: 10 to 20 days, with pauses .

Observations:
* Best taken 30 to 60 min before bed .
* Effects vary significantly between individuals .
* Does not typically cause dependence.